{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:15:41Z","timestamp":1785773741572,"version":"3.56.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Hold'em for Life Oncology Fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10549-025-07869-2","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T03:33:48Z","timestamp":1764646428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Using the cancer aging and research group- breast cancer (CARG-BC) predictive model in older adults (OA) with early breast cancer: an external validation study"],"prefix":"10.1007","volume":"215","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1839-8558","authenticated-orcid":false,"given":"Neha","family":"Pathak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Berner-Wygoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulaiman A.","family":"Almuthri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Theresa","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susie","family":"Monginot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabbir M. H.","family":"Alibhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4372-3204","authenticated-orcid":false,"given":"Michelle B.","family":"Nadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"7869_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"7869_CR2","unstructured":"Cancer of the Breast (Female) - Cancer Stat Facts. In: SEER. https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html. Accessed 17 Feb 2024"},{"key":"7869_CR3","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1634\/theoncologist.2014-0184","volume":"19","author":"EO Jenkins","year":"2014","unstructured":"Jenkins EO, Deal AM, Anders CK et al (2014) Age-specific changes in intrinsic breast cancer subtypes: a focus on older women. Oncologist 19:1076\u20131083. https:\/\/doi.org\/10.1634\/theoncologist.2014-0184","journal-title":"Oncologist"},{"issue":"1","key":"7869_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.14694\/EdBook_AM.2015.35.48","volume":"35","author":"RS Punglia","year":"2015","unstructured":"Punglia RS, Hughes KS, Muss HB (2015) Management of older women with early-stage breast cancer. Am Soc Clin Oncol Educ Book 35(1):48\u201355. https:\/\/doi.org\/10.14694\/EdBook_AM.2015.35.48","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"7869_CR5","doi-asserted-by":"publisher","first-page":"e2339116","DOI":"10.1001\/jamanetworkopen.2023.39116","volume":"6","author":"JC Baltussen","year":"2023","unstructured":"Baltussen JC, de Glas NA, van Holstein Y et al (2023) Chemotherapy-related toxic effects and quality of life and physical functioning in older patients. JAMA Netw Open 6:e2339116. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.39116","journal-title":"JAMA Netw Open"},{"key":"7869_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41523-024-00612-y","volume":"10","author":"I Grootes","year":"2024","unstructured":"Grootes I, Wishart GC, Pharoah PDP (2024) An updated PREDICT breast cancer prognostic model including the benefits and harms of radiotherapy. NPJ Breast Cancer 10:6. https:\/\/doi.org\/10.1038\/s41523-024-00612-y","journal-title":"NPJ Breast Cancer"},{"key":"7869_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1804710","volume":"379","author":"JA Sparano","year":"2018","unstructured":"Sparano JA, Gray RJ, Makower DF et al (2018) Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med 379:111\u2013121. https:\/\/doi.org\/10.1056\/NEJMoa1804710","journal-title":"N Engl J Med"},{"key":"7869_CR8","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","volume":"385","author":"K Kalinsky","year":"2021","unstructured":"Kalinsky K, Barlow WE, Gralow JR et al (2021) 21-gene assay to inform chemotherapy benefit in node-positive breast cancer. N Engl J Med 385:2336\u20132347. https:\/\/doi.org\/10.1056\/NEJMoa2108873","journal-title":"N Engl J Med"},{"key":"7869_CR9","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1158\/1078-0432.CCR-07-4723","volume":"14","author":"BS Wittner","year":"2008","unstructured":"Wittner BS, Sgroi DC, Ryan PD et al (2008) Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort. Clin Cancer Res 14:2988\u20132993. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4723","journal-title":"Clin Cancer Res"},{"key":"7869_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ejso.2011.02.001","volume":"37","author":"GC Wishart","year":"2011","unstructured":"Wishart GC, Bajdik CD, Azzato EM et al (2011) A population-based validation of the prognostic model PREDICT for early breast cancer. European Journal of Surgical Oncology (EJSO) 37:411\u2013417. https:\/\/doi.org\/10.1016\/j.ejso.2011.02.001","journal-title":"European Journal of Surgical Oncology (EJSO)"},{"key":"7869_CR11","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/jamaoncol.2020.7320","volume":"7","author":"KF Hoskins","year":"2021","unstructured":"Hoskins KF, Danciu OC, Ko NY, Calip GS (2021) Association of race\/ethnicity and the 21-gene recurrence score with breast cancer-specific mortality among US women. JAMA Oncol 7:370\u2013378. https:\/\/doi.org\/10.1001\/jamaoncol.2020.7320","journal-title":"JAMA Oncol"},{"key":"7869_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13058-022-01571-7","volume":"24","author":"M Crager","year":"2022","unstructured":"Crager M, Wijayawardana SR, Gruver AM et al (2022) Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score\u00ae result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2\u2212, node-positive early breast cancer. Breast Cancer Res 24:74. https:\/\/doi.org\/10.1186\/s13058-022-01571-7","journal-title":"Breast Cancer Res"},{"key":"7869_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ejca.2020.11.022","volume":"144","author":"NML Battisti","year":"2021","unstructured":"Battisti NML, Reed MWR, Herbert E et al (2021) Bridging the age gap in breast cancer: impact of chemotherapy on quality of life in older women with early breast cancer. Eur J Cancer 144:269\u2013280. https:\/\/doi.org\/10.1016\/j.ejca.2020.11.022","journal-title":"Eur J Cancer"},{"key":"7869_CR14","doi-asserted-by":"publisher","first-page":"101540","DOI":"10.1016\/j.jgo.2023.101540","volume":"14","author":"DJ Walsh","year":"2023","unstructured":"Walsh DJ, Sahm LJ, O\u2019Driscoll M et al (2023) Hospitalization due to adverse drug events in older adults with cancer: A retrospective analysis. J Geriatr Oncol 14:101540. https:\/\/doi.org\/10.1016\/j.jgo.2023.101540","journal-title":"J Geriatr Oncol"},{"key":"7869_CR15","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1200\/JCO.20.02063","volume":"39","author":"A Magnuson","year":"2021","unstructured":"Magnuson A, Sedrak MS, Gross CP et al (2021) Development and validation of a risk tool for predicting severe toxicity in older adults receiving chemotherapy for early-stage breast cancer. J Clin Oncol 39:608\u2013618. https:\/\/doi.org\/10.1200\/JCO.20.02063","journal-title":"J Clin Oncol"},{"key":"7869_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/ckj\/sfaa188","volume":"14","author":"CL Ramspek","year":"2020","unstructured":"Ramspek CL, Jager KJ, Dekker FW et al (2020) External validation of prognostic models: what, why, how, when and where? Clin Kidney J 14:49\u201358. https:\/\/doi.org\/10.1093\/ckj\/sfaa188","journal-title":"Clin Kidney J"},{"key":"7869_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jclinepi.2014.09.007","volume":"68","author":"GCM Siontis","year":"2015","unstructured":"Siontis GCM, Tzoulaki I, Castaldi PJ, Ioannidis JPA (2015) External validation of new risk prediction models is infrequent and reveals worse prognostic discrimination. J Clin Epidemiol 68:25\u201334. https:\/\/doi.org\/10.1016\/j.jclinepi.2014.09.007","journal-title":"J Clin Epidemiol"},{"key":"7869_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jclinepi.2014.06.018","volume":"68","author":"TPA Debray","year":"2015","unstructured":"Debray TPA, Vergouwe Y, Koffijberg H et al (2015) A new framework to enhance the interpretation of external validation studies of clinical prediction models. J Clin Epidemiol 68:279\u2013289. https:\/\/doi.org\/10.1016\/j.jclinepi.2014.06.018","journal-title":"J Clin Epidemiol"},{"key":"7869_CR19","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471\u20131474. https:\/\/doi.org\/10.1245\/s10434-010-0985-4","journal-title":"Ann Surg Oncol"},{"key":"7869_CR20","unstructured":"(2017) Common Terminology Criteria for Adverse Events (CTCAE). 155"},{"key":"7869_CR21","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1002\/ijc.33122","volume":"147","author":"F Riedel","year":"2020","unstructured":"Riedel F, Hoffmann AS, Moderow M et al (2020) Time trends of neoadjuvant chemotherapy for early breast cancer. Int J Cancer 147:3049\u20133058. https:\/\/doi.org\/10.1002\/ijc.33122","journal-title":"Int J Cancer"},{"key":"7869_CR22","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","volume":"376","author":"N Masuda","year":"2017","unstructured":"Masuda N, Lee S-J, Ohtani S et al (2017) Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med 376:2147\u20132159. https:\/\/doi.org\/10.1056\/NEJMoa1612645","journal-title":"N Engl J Med"},{"key":"7869_CR23","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa1814017","volume":"380","author":"G von Minckwitz","year":"2019","unstructured":"von Minckwitz G, Huang C-S, Mano MS et al (2019) Trastuzumab emtansine for residual invasive HER2-positive breast cancer. N Engl J Med 380:617\u2013628. https:\/\/doi.org\/10.1056\/NEJMoa1814017","journal-title":"N Engl J Med"},{"key":"7869_CR24","doi-asserted-by":"publisher","first-page":"100059","DOI":"10.1016\/j.soi.2024.100059","volume":"1","author":"AS Baskin","year":"2024","unstructured":"Baskin AS, Huppert LA, Kelil T et al (2024) The neoadjuvant approach to treatment of breast cancer: multidisciplinary management to improve outcomes. Surgical Oncology Insight 1:100059. https:\/\/doi.org\/10.1016\/j.soi.2024.100059","journal-title":"Surgical Oncology Insight"},{"key":"7869_CR25","doi-asserted-by":"publisher","first-page":"101814","DOI":"10.1016\/j.jgo.2024.101814","volume":"15","author":"M Uchiyama","year":"2024","unstructured":"Uchiyama M, Miyazaki M, Hayashi T et al (2024) Assessing the ability of the Cancer and Aging Research Group tool to predict chemotherapy toxicity in older Japanese patients: a prospective observational study. J Geriatr Oncol 15:101814. https:\/\/doi.org\/10.1016\/j.jgo.2024.101814","journal-title":"J Geriatr Oncol"},{"key":"7869_CR26","doi-asserted-by":"publisher","first-page":"e2237196","DOI":"10.1001\/jamanetworkopen.2022.37196","volume":"5","author":"A Pang","year":"2022","unstructured":"Pang A, Jiali L, Ng A et al (2022) Use of the Cancer and Aging Research Group predictive model for chemotherapy-related toxic effects in a multiethnic, older adult Asian population. JAMA Netw Open 5:e2237196. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.37196","journal-title":"JAMA Netw Open"},{"key":"7869_CR27","doi-asserted-by":"publisher","first-page":"e047376","DOI":"10.1136\/bmjopen-2020-047376","volume":"11","author":"V Ostwal","year":"2021","unstructured":"Ostwal V, Ramaswamy A, Bhargava P et al (2021) Cancer Aging Research Group (CARG) score in older adults undergoing curative intent chemotherapy: a prospective cohort study. BMJ Open 11:e047376. https:\/\/doi.org\/10.1136\/bmjopen-2020-047376","journal-title":"BMJ Open"},{"key":"7869_CR28","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","volume":"29","author":"A Hurria","year":"2011","unstructured":"Hurria A, Togawa K, Mohile SG et al (2011) Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 29:3457\u20133465. https:\/\/doi.org\/10.1200\/JCO.2011.34.7625","journal-title":"J Clin Oncol"},{"key":"7869_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12877-025-05722-1","volume":"25","author":"D Lingamaiah","year":"2025","unstructured":"Lingamaiah D, Bushi G, Gaidhane S et al (2025) Falls among geriatric cancer patients: a systematic review and meta-analysis of prevalence and risk across cancer types. BMC Geriatr 25:179. https:\/\/doi.org\/10.1186\/s12877-025-05722-1","journal-title":"BMC Geriatr"},{"key":"7869_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjonc-2024-000459","author":"MA Baxter","year":"2024","unstructured":"Baxter MA, Rowe M, Zucker K et al (2024) UK national observational cohort study investigating tolerance of anti-cancer systemic therapy in the elderly: the TOASTIE study. bmjonc. https:\/\/doi.org\/10.1136\/bmjonc-2024-000459","journal-title":"bmjonc"},{"key":"7869_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1200\/JCO.2020.39.28_suppl.209","volume":"39","author":"A Mbewe","year":"2021","unstructured":"Mbewe A, Pike P, Lewis R et al (2021) Implementing the cancer and aging research group (CARG) tool in the ambulatory oncology setting to drive informed treatment selection. J Clin Oncol 39:209\u2013209. https:\/\/doi.org\/10.1200\/JCO.2020.39.28_suppl.209","journal-title":"J Clin Oncol"},{"key":"7869_CR32","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1200\/JCO.2017.72.8170","volume":"35","author":"ME Hamaker","year":"2017","unstructured":"Hamaker ME, Wildes TM, Rostoft S (2017) Time to stop saying geriatric assessment is too time consuming. J Clin Oncol 35:2871\u20132874. https:\/\/doi.org\/10.1200\/JCO.2017.72.8170","journal-title":"J Clin Oncol"},{"issue":"4","key":"7869_CR33","doi-asserted-by":"publisher","first-page":"e24465","DOI":"10.7759\/cureus.24465","volume":"14","author":"ME Mintchev","year":"2022","unstructured":"Mintchev ME, Kalra AG, Kou C-TJ et al (2022) Use of a chemotherapy toxicity prediction tool to decrease risks for hospitalization in older patients. Cureus 14(4):e24465. https:\/\/doi.org\/10.7759\/cureus.24465","journal-title":"Cureus"},{"key":"7869_CR34","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1200\/JCO.2018.78.8687","volume":"36","author":"SG Mohile","year":"2018","unstructured":"Mohile SG, Dale W, Somerfield MR et al (2018) Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology. J Clin Oncol 36:2326\u20132347. https:\/\/doi.org\/10.1200\/JCO.2018.78.8687","journal-title":"J Clin Oncol"},{"key":"7869_CR35","doi-asserted-by":"publisher","first-page":"30077","DOI":"10.1038\/s41598-024-80064-3","volume":"14","author":"S Grim","year":"2024","unstructured":"Grim S, Kotz A, Kotz G et al (2024) Development and validation of electronic health record-based, machine learning algorithms to predict quality of life among family practice patients. Sci Rep 14:30077. https:\/\/doi.org\/10.1038\/s41598-024-80064-3","journal-title":"Sci Rep"},{"key":"7869_CR36","doi-asserted-by":"publisher","first-page":"e0202344","DOI":"10.1371\/journal.pone.0202344","volume":"13","author":"AJ Steele","year":"2018","unstructured":"Steele AJ, Denaxas SC, Shah AD et al (2018) Machine learning models in electronic health records can outperform conventional survival models for predicting patient mortality in coronary artery disease. PLoS ONE 13:e0202344. https:\/\/doi.org\/10.1371\/journal.pone.0202344","journal-title":"PLoS ONE"},{"key":"7869_CR37","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1200\/CCI.21.00116","volume":"5","author":"DJ Peterson","year":"2021","unstructured":"Peterson DJ, Ostberg NP, Blayney DW et al (2021) Machine learning applied to electronic health records: identification of chemotherapy patients at high risk for preventable emergency department visits and hospital admissions. JCO Clin Cancer Inform 5:1106\u20131126. https:\/\/doi.org\/10.1200\/CCI.21.00116","journal-title":"JCO Clin Cancer Inform"},{"key":"7869_CR38","doi-asserted-by":"publisher","first-page":"102853","DOI":"10.1016\/j.canep.2025.102853","volume":"97","author":"Z Wang","year":"2025","unstructured":"Wang Z, Wang T, Xie Y et al (2025) Unraveling the role of adjuvant chemotherapy in elderly triple-negative breast cancer: insights from competing risk analysis using SEER data. Cancer Epidemiol 97:102853. https:\/\/doi.org\/10.1016\/j.canep.2025.102853","journal-title":"Cancer Epidemiol"},{"key":"7869_CR39","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1200\/JCO.2013.55.0418","volume":"32","author":"A Hurria","year":"2014","unstructured":"Hurria A, Dale W, Mooney M et al (2014) Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations. J Clin Oncol 32:2587\u20132594. https:\/\/doi.org\/10.1200\/JCO.2013.55.0418","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07869-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-025-07869-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07869-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:39:08Z","timestamp":1767789548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-025-07869-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["7869"],"URL":"https:\/\/doi.org\/10.1007\/s10549-025-07869-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7468335\/v1","asserted-by":"object"}]},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Michelle Nadler reports speaker honorarium and consulting fees from Novartis and Exact Sciences, outside of the scope of this submitted work. Neha Pathak received salary support as a clinical fellow through the Hold\u2019em for Life Oncology Fellowship, for purposes of conducting this study.The remaining authors have no conflicts with the present work. No authors report competing interests with present work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study received approval by the Institute\u2019s Research Ethics Board (Letter 23\u20135820) prior to initiating the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"As this was a retrospective study, the need for informed patient consent was waived by the Institute\u2019s Research Ethics Board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"As this was a retrospective study of de-identified data, the need for informed patient consent to publish was waived by the Institute\u2019s Research Ethics Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"24"}}